Synaptrix Labs , a startup building a wearable brain-computer interface platform recently secured seed funding from Mark Cuban to accelerate commercial traction.

Neuralis is the company’s wearable BCI headset targeting the motor cortex, with dry sensors and on-device signal processing that “decodes subtle EEG signals, effectively translating them into precise wheelchair navigation commands.” The company is prioritizing wheelchair users as their first market through a clinical trial with Columbia University.

Those capabilities are powered by NeuroDiffusion, an AI platform to enable development of both clinical and consumer applications. I recently spoke with CEO and co-founder Aryan Govil to understand his strategy across neurotech markets.

“The future of neurotech lies in deep lear

See Full Page